A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancer
Abstract This multi-site, double blind, parallel arm, fixed dose, randomised placebo controlled phase III study compared megestrol acetate 480 mg/day with dexamethasone 4 mg/day for their net effects on appetite in people with cancer anorexia. Patients with advanced cancer and anorexia for ≥ 2 weeks...
Guardado en:
Autores principales: | David C. Currow, Paul Glare, Sandra Louw, Peter Martin, Katherine Clark, Belinda Fazekas, Meera R. Agar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/67f926cdbd9d47eab5c183444516b62a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Food effect on the bioavailability of two distinct formulations of megestrol acetate oral suspension
por: Benoit Deschamps, et al.
Publicado: (2009) -
Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial.
por: Chris Fox, et al.
Publicado: (2012) -
Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial.
por: Sanjay Patole, et al.
Publicado: (2014) -
Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study
por: Lars Lonn, et al.
Publicado: (2021) -
A prospective randomised double-blind placebo-controlled trial to assess the effect of diuretics on shockwave lithotripsy of calculi
por: Sagar Sabharwal, et al.
Publicado: (2017)